Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-05
1993-08-17
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514318, 514319, 514323, 514324, 514327, 514329, 514330, 514331, 544336, 544405, 544408, 544409, 546193, 546194, 546201, 546207, 546208, 546209, 546214, 546217, 546221, 546225, 546228, 546229, 546231, 546233, 546331, C07D21132, C07D24100, A01N 4340
Patent
active
052369218
ABSTRACT:
The invention relates to compounds of formula: ##STR1## in which Y represents--either a group Cy--N in which
REFERENCES:
patent: 3103516 (1963-09-01), Scmitt et al.
patent: 4751327 (1988-06-01), Kazmaier et al.
patent: 4916156 (1990-04-01), Moose et al.
patent: 4920116 (1990-04-01), Morgan, Jr. et al.
A. Donetti, el. Marazzi-Uberti: "Central Nervous System Activity of Ethyl 1-Naphthylalkylcarbamates", Journal of Medicinal Chemistry, vol. 13, No. 4, 1970, pp. 747-448.
Chemical Abstracts, vol. 109, No. 17, Oct. 23, 1988, p. 53, "A novel series of potent and selective agonists at the opioid kappa-receptor".
Chemical Abstracts, vol. 111, No. 3, Jul. 17, 1989, p. 47, "ICI 204448: a kappa-opioid agonist with limited access to the CNS".
Broeck Didier Van
Emonds-Ai Xavier
Goulaouic Pierre
Proietto Vincenzo
Covington Raymond
Ivy C. Warren
Sanofi
LandOfFree
Arylalkylamines, process for preparing them and pharmaceutical c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylalkylamines, process for preparing them and pharmaceutical c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylalkylamines, process for preparing them and pharmaceutical c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243849